Introduction
Effluents from municipal wastewater treatment plants (WWTPs) contain pharmaceuticals (typically µg/L), as many of these compounds are not removed in traditional wastewater treatment processes (Falås et al., 2012a; Wang et al., 2015) . As pharmaceuticals are designed to have biological effects, it is inevitable that they can 2 potentially have effects on aquatic life, and thus regulation authorities increasingly develop water quality criteria for pharmaceuticals in the ng/L and µg/L ranges, which is not achievable with currently used wastewater treatment methods (Álvarez-Muñoz et al., 2015) . Therefore, there is of increasing interest to understand the mechanisms of the removal of pharmaceuticals in the wastewater treatment processes and identify technologies that can achieve better removal.
Besides chemical methods for polishing pharmaceuticals in wastewater effluents such as ozonation (Hansen et al., 2016) , biofilm methods are being investigated as methods to improve removal of pharmaceuticals from wastewater (Escolà Casas et al., 2015; Falås et al., 2013 Falås et al., , 2012b Joss et al., 2004) . The moving bed biofilm reactor (MBBR) consists of a wastewater reactor containing suspended plastic carriers that serve as support to biofilm growth, making it possible to utilise the whole tank volume for biomass growth (Ødegaard, 2006) . Over the past decades, MBBR have been used successfully to treat different types of wastewater containing organic chemicals of concern (Borghei and Hosseini, 2004; Chen et al., 2007; Escolà Casas et al., 2015) .
Previous studies have already demonstrated that MBBR reactors achieve similar or better biodegradation efficiencies for micropollutants compared to activated sludge treatment. (Escolà Casas et al., 2015; Falås et al., 2012b; Mazioti et al., 2015) Biomass communities found in wastewater treatment facilities are related to the conditions under which they grow (Cydzik-Kwiatkowska and Zielińska, 2016 ). An important parameter for these conditions is the type and concentration of carbon in wastewater. However, there is a lack of knowledge on how this parameter affects biofilm activity. Biodegradation of micropollutants may interact with organic matter by two types of mechanisms: co-metabolism and competitive inhibition. The terms 'co-3 metabolism' and 'competitive inhibition' will be used in this article as defined below because they were found to be the most suitable. It is important to notice that such terms do not exactly correspond to their definition in biochemistry.
Co-metabolism involves the transformation of a non-growth substrate (pharmaceutical) in the obligate presence of a substrate that is utilised by the biomass for growth. Nongrowth substrate refers to compounds that are unable to support cell replication at the given concentrations (Dalton et al., 1982) , such as micropollutants in realistic wastewater conditions. Namely, the obligatory presence of a growth substrate or another utilisable compound is essential to the main biomass and induces enzymes for assimilation or co-factors for biodegradation (Arp et al., 2001) . Some relevant studies in the literature have found that phenol and glucose act as primary growth substrates and enhance the biodegradation of 4-chlorophenol, which is considered a non-growth substrate at low concentrations (Tobajas et al., 2012) . Essentially under such conditions the higher the substrate concentration, the faster the degradation of the pollutant.
Competitive inhibition proposes that, a pollutant and the usual grow substrate compete for active sites (e.g. of enzymes) for being processed. Thus the higher the substrate concentration the slower the degradation of the pollutant (Chang and Alvarez-Cohen, 1995) . To minimise and optimise the discrepancy between the observed removal and estimated removal of micropollutants, previous studies in the literature demonstrate that the ability of the model used to predict micro-pollutant degradation improved after the addition of an parameter regarding competitive inhibition (Plósz et al., 2010) .
Experimentally, Joss et al. (2004) found that differences in the removal rates of oestrogens, between the batch experiment and the corresponding compartment of fullscale plants, could be interpreted in terms of the competitive inhibition of oestrogen 4 degradation by the substrate. This was explained because the batch experiments were run without adding a primary effluent, while the full-scale plants were operated under regular conditions (Joss et al., 2004) .
According to the descriptions above, co-metabolism and competitive inhibition thus make opposite predictions on the effect of substrate on pollutant removal.
The aim of this study was to investigate the effect of additional carbon sources on the removal of micropollutants by biofilms. Specifically, laboratory-scale MBBRs were used to mimic a potential treatment for effluent wastewater from a CAS treatment plant.
In this test, humic acid (HA) was chosen to simulate different concentrations of complex carbon (i.e. not easily biodegradable carbon) as a carbon source (feed) to induce biological activity. This way it was tested whether enhanced carbon loads are beneficial or detrimental to degradation of recalcitrant compounds (meaning whether the effect of co-metabolism or competitive inhibition by additional carbon is predominant).
Methods

Chemicals
The investigated micropollutants include antibiotics (azithromycin, ciprofloxacin, sulfadiazine, sulfamethizole, sulfamethoxazole, trimethoprim and the sulfadiazine metabolite acetyl-sulfadiazine), beta-blockers (atenolol, metoprolol, propranolol and sotalol), antindepressants/antiepileptics (venlafaxine and carbamazepine), analgesics (diclofenac, ibuprofen, phenazone and tramadol) and X-ray contrast media (iopromide, iohexol and iopamidol). The investigated compounds were obtained from different suppliers, as described in the supplementary information (SI ; Table S1 ). Formic acid 5 and gradient-grade methanol were obtained from Merck (Darmstadt, Germany). Humic acid sodium salt was purchased from Sigma-Aldrich (Steinheim, Germany), and water of a gradient grade came from Sigma-Aldrich (Munich, Germany).
Instruments
The HPLC was equipped with a dual low-pressure mixing ternary gradient system, namely Ultimate 3000, from Dionex. This system consisted of a pump, a column oven and a degasser, which were all 3000 series, and a 3000 TSL autosampler (WPS 3000 TSL). The mass spectrometer was an API 4000 (ABSciex, Framingham, MA, USA).
The HPLC-MS/MS conditions are the same as the supplementary information (S2) in Escolà Casas et al. (2015) .
Wastewater and the growth of biofilm carriers
The effluent wastewater used for the growth of the biofilm carriers and for the experiment was collected from Bjergmarken WWTP in Roskilde, Denmark.
Bjergmarken WWTP is a classical activated sludge plant, with nitrification and denitrification as well as biological phosphorus removal. The wastewater was stored at 4°C and before starting the experiment it was allowed to reach room temperature. The characteristics of the wastewater in this experiment are presented in Table S2 .
To grow the biofilm on the carriers, 150 new MBBR-carriers K5 (800m 2 /m 3 specific surface area) from AnoxKaldnes TM (AnoxKaldnes, Lund, Sweden) were incubated in a beaker containing 1500 mL of the described effluent wastewater. The carriers were stirred with a magnetic stir-bar and the wastewater was fully changed three times a week. No additional aeration was performed, as oxygen consumption in the system was very low. These conditions were maintained for four months. At that time, the carriers were ready for the batch experiment. 
Experimental design and procedure
The experiment consisted in testing the degradation of spiked pharmaceuticals in secondary treated wastewater in the presence of three defined concentrations of humic acid (all in triplicates). Humic acid sodium salt was used in this experiment, as it is easier to solubilise than natural, isolated humic acid. To prepare solutions of humic acid 4.9, 7.4 or 24.7 mg humic acid sodium salt were added into 200 mL volumetric flasks which were filled with effluent from Bjergmarken WWTP.
For the spiking, 10 μL of a stock solution containing pharmaceuticals in methanol were transferred to 100 mL Erlenmeyer flasks. After the methanol had evaporated, 40 mL of the previous humic acid sodium salt solutions in effluent water were introduced into the respective flasks. This gave initial concentrations of the pharmaceuticals ranging between 1.2 and 14.6 µg/L.
When the flasks were prepared, three carriers with biofilm were placed into each of them. This resulted in a filling ratio of 23%, corresponding to 104 m 2 /m 3 surface area, which was kept constant (maximum variations of ±3%) by adjusting the number of carriers to the remaining water at certain time-points after sampling. The experiment was more optimised for gaining comparable and stable results than for working at optimal filling ratio. The Erlenmeyer flasks were placed on a mechanical shaker (120 rpm) for a period of two weeks. The design of the experiment is shown in Table S3 .
Quantification and analysis
General parameters
Dissolved oxygen and pH were measured with a multi-parameter meter (Multi 3420, WTW), while dissolved organic carbon (DOC) concentration was analysed by a total organic carbon analyser (Shimadzu, TOC-V wp with ASI-V, Japan). COD and other 7 parameters mentioned for wastewater in the effluent from Bjergmarken WWTP (Table   S2) Biomass on the MBBR carriers was determined by using a digital balance (Sartorius Basic, BP 210D) and a drying oven (SalvisLab Thermocenter, TC40). To do so, two carriers from each flask, and new carriers without biofilm, were placed in an aluminium foil cup, dried overnight at 105°C and then weighed. Differences in weight between the new carriers and carriers with biofilm coverage were used as the dry biomass content.
Pharmaceuticals analysis
For the analysis of pharmaceuticals, for each time-point and flask, 1 mL of water was taken with an Eppendorf pipette and directly put into HPLC vials. The samples were immediately stored at -20°C. Before analysis they were brought up to room temperature and centrifuged for 10 min at 6000 rpm. Afterwards, 900 μL of the supernatant were transferred to a new HPLC vial by using a glass syringe. Subsequently, 100 μL of internal standard solution (sulfadiazine 
Data treatment
Quantification was done via Analyst 1.6. After quantification, all of the concentrations were fitted with single first-order degradation kinetics One degradation rate constant (k) was assumed to be valid over the entire period. 
Results and discussion
General parameters
The initial pH values of the reactors increased slightly in correspondence with increasing concentrations of added humic acid sodium salt, which is consistent with the fact that salt is alkaline. The pH increased further during the experiment, which could be explained by the mineralization of the humic acid that would leave an equivalent amount of alkalinity (Table 1) .
The biomass on the carriers was calculated to correspond to 2.5 g of dry matter per litre (33 mg/carrier). The quantified biomass was lower in this work than in previous studies, that is that the biofilm in the present study was cultured on wastewater treatment plant effluent, which contained considerable lower organic matter concentrations than the MBBR reactors in literature working on wastewater. Furthermore, the carriers filling ratio of this study (23%) was also lower than both values from Escola Casas et al. (2015) with 50% and Falås et al. (2013) with 35% which was fine for a mechanistic study such as this experiment. This could have been a consequence of the sampling procedure, which might have added impurities to the samples. On the contrary, the flasks spiked with humic acid exhibited decreasing DOC during the experiment, which is most likely because of the humic acid mineralisation, as also suggested from the increasing pH. In this case, the decrease of DOC due to mineralisation could have over-compensated the increase of DOC due to the sampling. Interestingly, the DOC in the flask spiked with the highest amount of humic acid was observed to decrease proportionally much more than the flasks spiked with lower levels of humic acid. As it might be expected that the biodegradable fraction of the humic acid is constant it could be expected that some of it, due to the higher concentration and pH, precipitated on the glass or aggregated to smaller particles which were not measured in the DOC analysis.
Removal of pharmaceuticals
The removal of pharmaceuticals was assessed by measuring the concentrations of the pharmaceuticals during the experiment. To do so, the concentrations of pharmaceuticals were plotted vs time. The data were fitted, when possible, to single first-order degradation kinetics as explained in Section 2.5.3. The measurements and fittings can be seen in Figure 1 for six representative compounds and in Figure S1 in the SI for the rest of compounds.
13 out of 22 compounds were biodegraded by the biofilm. This could be confirmed because the control flasks showed much slower removal than the test flasks (mediated by biomass suspended in water). Single first-order kinetics could be fitted with R 2 higher than 0.8 for these 13 compounds. The removal rate constants (k from Equation 1) for the different additions of humic acid ( Figure 2 and Table 2 ) were used to further 10 investigate the effect of humic acid on the biodegradation of pharmaceuticals (Section 3.3). It was known that diclofenac was one of the most persistent compounds, and its rate constant in this study was also lower than most of the investigated compounds. Tran et al. (2009) investigated that the biodegradation of ten pharmaceuticals by an enriched nitrifier culture and found poor biodegradation removal of compounds containing at least one chlorine group in the molecular structure, such as clofibric acid and diclofenac. In this case, the chemical structure may hinder biotransformation processes.
The biofilm on the carriers was not able to degrade 9 out of 22. Some compounds presented no significant removal in both, controls and test flasks (phenanzone, sulfadiazine, sulfamethoxazole, tramadol and venlafaxine) ( Figure S1 ). This indicated that those compounds were not degradable under the test conditions (test flasks). Other compounds showed removal rates that were significant but not statistically different from the control (azithromycin, clarithromycin, erythromycin, roxithromycin). For these compounds degradation in the control reactor was detected. This might be due to either biodegradation by bacteria present in the effluent wastewater in suspension or abiotic reactions. Furthermore, hydrolysis or photolysis might lead to slightly reduce the concentrations of pharmaceuticals as well. In this case, even if the compounds were degradable in the test conditions, it was thus not possible to distinguish between the removal by suspended bacteria and the removal mediated by the biofilm. Therefore the effect of the humic acid addition was not assessed for these nine compounds.
In order to make the results comparable with other studies in the literature, the removal rate constants (k) were normalized to the biomass content of the carriers (k bio [h
Compared to previous investigations on the degradation of pharmaceuticals by MBBR, 11 the k bio values in this work are ten to hundred times lower (Table S4 ) than those described for the same pharmaceuticals by Escolà Casas et al. (2015) and Falås et al. (2013) . An explanation for this might be that the biofilm investigated in this study was grown as polishing reactor in effluent wastewater and it was thus acclimatised to lower C loads. Therefore, the biofilm was probably adapted to slow metabolism as an adaptation to the low-nutrient environment.
Influence of humic acid on pharmaceutical degradation
Considering the removal rate constants of the 13 pharmaceuticals which exhibited biodegradation, it is clear that increasing the DOC by adding humic acid affected the degradation kinetic of pharmaceuticals. To create an overview of the influence of the initial DOC on the kinetic of pharmaceutical biodegradation, degradation rate constants of the six representative compounds are shown in Figure 2 (all pharmaceuticals are shown in Figure S2 ).
All the biodegradable pharmaceuticals appeared to degrade faster in test flasks with increased humic acid concentration. Regarding the mentioned theories on the interaction of organic carbon with biodegradation (Section 1), it thus appears that increased "cometabolism" is the main effect of increased humic acid concentration for the studied compounds. Competitive inhibition appears not to be relevant for humic acid interactions with the biodegradation of pharmaceuticals. Furthermore, based on the low COD values of the wastewater (described in Table S2 ) and continuous shaking during the experiment (dissolved oxygen measured at 8 mg/L), co-metabolic degradation of pharmaceuticals occurred. This means that pharmaceuticals were oxidised by an 12 enzyme or co-factor produced during the microbial metabolism of another growth substrate with oxygen (Tran et al., 2013) .
Relationship between total concentration of organic matter and rate constant
The relation between k and the initial DOCs for the biodegradable pharmaceuticals was plotted and it is shown in Figure 3 and Table 2 . According to the fittings, the slopes of 10 out of 13 compounds are positive, which suggest that the addition of humic acid stimulates the biodegradation of pharmaceuticals in biofilms. Based on the slope, the effect of initial DOC on k could be stated to be stimulated from -0.6% to 26% per mgC/L. The average stimulation of for all biodegradable pharmaceuticals was 7.4% per mgC/L and the 25%, 50 % and 75% percentiles were 2.8, 6.4 and 8.7 % per mgC/L, respectively. As the effect of DOC for half of the biodegradable compounds fall in a relatively narrow range we propose that this can be used as a default value in modelling the effect of increased DOC in a WWTP in cases there a specific value isn't known for a pharmaceutical.
As results in Figure 3 , the flasks containing the highest level of DOC (initially 30 mgC/L) gave rate constant double or triple the values obtained for the flasks without addition of humic acid (initially 4.4 mgC/L). Taking this into account, it seems that the addition of carbon can enhance the efficiency of MBBR reactors. Therefore, further studies with more concentration levels should be done to establish precise correlations between the levels of DOC and the removal of pharmaceuticals in water.
Conclusion
Generally, the majority of biodegradable pharmaceuticals degraded faster at higher DOC levels. This indicates that co-metabolism may be the most important mechanism 13 when humic acids interact with the degradation of pharmaceuticals. The average stimulation of the first-order degradation rate for biodegradable pharmaceuticals was 5% per mg DOC. 30 mgC/L by humic acid addition enhanced about three times the biodegradation performance of the laboratory-scale MBBRs.
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